mGlu2 mechanism-based interventions to treat alcohol relapse

Area of Science:

• Neuroscience
• Pharmacology
• Addiction Research

Background:

• A deficiency in metabotropic glutamate receptor 2 (mGlu2) function is linked to alcohol-seeking and relapse behaviors.
• mGlu2/3 agonists and mGlu2 positive allosteric modulators (PAMs) are hypothesized to reduce relapse-like behavior.

Purpose of the Study:

• To investigate the efficacy of mGlu2/3 agonists and a specific mGlu2 PAM in reducing alcohol relapse behaviors in a rat model.
• To assess potential side effects, tolerance development, and sex differences in response to these treatments.

Main Methods:

• Utilized the alcohol deprivation effect (ADE) rat model with repeated deprivation phases.
• Administered mGlu2/3 agonists (LY379268, LY354740) and an mGlu2 PAM (LY487379).
• Monitored water intake, body weight, locomotor activity, and ADE expression.

Main Results:

• Both mGlu2/3 agonists and the mGlu2 PAM significantly reduced ADE expression in a dose-dependent manner.
• No significant changes in water intake, body weight, or locomotor activity were observed.
• Repeated agonist administration did not induce tolerance, and the mGlu2 PAM was effective in both male and female rats.

Conclusions:

• mGlu2/3 agonists and mGlu2 PAMs are effective in reducing alcohol relapse-like behavior.
• mGlu2 PAMs demonstrate potential for clinical trials in treating alcohol dependence.
• Targeting mGlu2 represents a promising therapeutic strategy for alcohol relapse prevention.